Prognostic and predictive investigation of PAM50 intrinsic subtypes in the NCIC CTG MA.21 phase III chemotherapy trial
暂无分享，去创建一个
T. Nielsen | E. Perez | T. Whelan | K. Gelmon | H. Rugo | Shuzhen Liu | K. Albain | K. Pritchard | J. Chapman | M. Levine | L. Shepherd | D. Gao | S. Virk | M. Burnell | P. O’Brien | Garrett S. Barry